About iDMT
The mission of the Innovation Centre in Digital Molecular Technologies (iDMT) is to create opportunities for a thriving society through innovative sustainable and resilient chemistry.
​
The iDMT offers a platform for the rapid development and testing of new products and services for the emerging digital economy, specifically in the sectors of chemical synthesis of molecules and materials.
​
​Business support from the iDMT includes access to lab space and a collaborative research environment; participation in joint development with leading researchers from academia and the pharmaceutical industry; and access to equipment, materials and computational resources.
Research Areas
The iDMT works with industry to help develop new products and services to serve the emerging digital chemistry market. The iDMT undertakes collaborative research projects in three key digital molecular technology areas:
Artificial intelligence in molecular technologies
Robotic equipment for chemical synthesis
Algorithms for digital process development
iDMT Team
The iDMT team is composed of:
-
World leading experts from the University of Cambridge in fields including sustainable engineering, probabilistic machine learning and chemical synthesis.
-
Insights from industrial partners.
Director
Professor Alexei Lapkin
AstraZeneca Management Board Member
Dr Clive Green
Shionogi Management Board Member
Dr Makoto Kawai
Research Lead
Dr Alpha Lee
Research Lead
Dr Jose Miguel Hernandez Lobato
University of Cambridge Researcher
Dr Emily Faulkner
PhD Student
Zhimian Hao
PhD Student
Joseph Phelps
PhD Student
Jana Weber
Co-Director
Professor Matthew Gaunt
AstraZeneca Management Board Member
Dr Michael Kossenjans
Administrator
Kerstin Enright
Research Lead
Dr Sebastian Ahnert
University of Cambridge Researcher
Dr Tania Xavier
Shionogi Researcher
Dr Akihiro Takada
PhD Student
Anna Katsarou
PhD Student
Alexander Pomberger
PhD Student
Daniel Wigh
Shionogi Management Board Member
Dr Kenji Yamawaki
Research Lead
Professor Jonathan Goodman
Research Lead
Dr Laura Torrente Murciano
University of Cambridge Researcher
Dr Abigail Barker-Mountford
AstraZeneca Researcher
Dr Hanna Maliszewska
PhD Student
Antonio Pedrina
PhD Student
Milo Smith
Centre of Excellence Members
Creating opportunities for a thriving society through the use of digital molecular technologies for scientific discovery and process development, supporting the transition of industry towards innovative, sustainable and resilient chemistry.